Biotech fall leads to buying opportunitiy: Analyst By: CNBC.com News September 29, 2015 at 17:13 PM EDT With the IBB performing poorly and increased confusion in the biotech market, is it time for investors to be bullish? Read More >> Related Stocks: Amgen Gilead Sciences Nasdaq Biotechnology Ishares ETF Regeneron Pharmaceuticals